These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34818767)

  • 61. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antibody Responses and CNS Pathophysiology of Mucormycosis in Chronic SARS Cov-2 Infection: Current Therapies Against Mucormycosis.
    Beeraka NM; Liu J; Sukocheva O; Sinelnikov MY; Fan R
    Curr Med Chem; 2022; 29(32):5348-5357. PubMed ID: 35538800
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Past, Present and Future of COVID-19 Associated Mucormycosis: A Rapid Review.
    Sarfraz Z; Sarfraz A; Jaiswal V; Poudel S; Bano S; Hanif M; Singh Shrestha P; Sarfraz M; Michel G; Cherrez-Ojeda I
    J Prim Care Community Health; 2022; 13():21501319221099476. PubMed ID: 35587142
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Risk factors for severe rhino-orbital mucormycosis during its epidemic post-COVID-19 pandemic.
    Das GK; Singh A; Beri N; Sahu PK; Bisht T; Sharma I
    Indian J Public Health; 2022; 66(4):494-497. PubMed ID: 37039180
    [TBL] [Abstract][Full Text] [Related]  

  • 65. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.
    Guzmán-Castro S; Chora-Hernandez LD; Trujillo-Alonso G; Calvo-Villalobos I; Sanchez-Rangel A; Ferrer-Alpuin E; Ruiz-Jimenez M; Corzo-Leon DE
    Mycoses; 2022 Jan; 65(1):65-70. PubMed ID: 34674319
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fostering a deeper understanding of COVID-19-associated mucormycosis - A commentary on "The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum" (Int. J. Surg. 2021:106031).
    MohanaSundaram A; Sathanantham ST; Chinchole V; Patil B; Velayutham R
    Int J Surg; 2021 Oct; 94():106110. PubMed ID: 34534704
    [No Abstract]   [Full Text] [Related]  

  • 68. Association of COVID with Mycosis in General.
    Kaur G; Kaur R; Kaur S; Kaur M
    Infect Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38251692
    [TBL] [Abstract][Full Text] [Related]  

  • 69. COVID-19 Associated Mucormycosis: A Systematic Review from Diagnostic Challenges to Management.
    Yasmin F; Najeeb H; Naeem A; Dapke K; Phadke R; Asghar MS; Shah SMI; De Berardis D; Ullah I
    Diseases; 2021 Sep; 9(4):. PubMed ID: 34698143
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mucormycosis Epidemic and Stroke in India During the COVID-19 Pandemic.
    Padma Srivastava MV; Vishnu VY; Pandit AK
    Stroke; 2021 Oct; 52(10):e622-e623. PubMed ID: 34525840
    [No Abstract]   [Full Text] [Related]  

  • 71. COVID-19 and the alarming rise of "black fungus" (mucormycosis) infection.
    Khajotia R
    Pan Afr Med J; 2022; 41():318. PubMed ID: 35865834
    [TBL] [Abstract][Full Text] [Related]  

  • 72. COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping.
    Hussain S; Baxi H; Riad A; Klugarová J; Pokorná A; Slezáková S; Líčeník R; Najmi AK; Klugar M
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639637
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sinonasal mucormycosis during 2 years of COVID-19 pandemic in central Iran: incidence rate and clinical features.
    Dadgarnia M; Mandegari M; Baradaranfar M; Vaziribozorg S; Abdollahpour M
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(5):298-304. PubMed ID: 36966984
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rampant Increase in Cases of Mucormycosis in India and Pakistan: A Serious Cause for Concern during the Ongoing COVID-19 Pandemic.
    Ghazi BK; Rackimuthu S; Wara UU; Mohan A; Khawaja UA; Ahmad S; Ahmad S; Hasan MM; Dos Santos Costa AC; Ahmad S; Essar MY
    Am J Trop Med Hyg; 2021 Aug; 105(5):1144-1147. PubMed ID: 34460426
    [TBL] [Abstract][Full Text] [Related]  

  • 75. COVID-19-associated mucormycosis: An updated systematic review of literature.
    Pal R; Singh B; Bhadada SK; Banerjee M; Bhogal RS; Hage N; Kumar A
    Mycoses; 2021 Dec; 64(12):1452-1459. PubMed ID: 34133798
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease.
    Narayanan S; Chua JV; Baddley JW
    Clin Infect Dis; 2022 Apr; 74(7):1279-1283. PubMed ID: 34420052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.
    Dallalzadeh LO; Ozzello DJ; Liu CY; Kikkawa DO; Korn BS
    Orbit; 2022 Oct; 41(5):616-619. PubMed ID: 33752571
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.
    Rashbi K S; Ali TMF; P N D; C K S; Payyappilly RJ
    Access Microbiol; 2022 Aug; 4(6):acmi000360. PubMed ID: 36004359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.
    Arora S; Hemmige VS; Mandke C; Chansoria M; Rawat SK; Dravid A; Sethi Y; Medikeri G; Jariwala SP; Puius YA;
    Emerg Infect Dis; 2021; 27(11):2963-2965. PubMed ID: 34586056
    [TBL] [Abstract][Full Text] [Related]  

  • 80. COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.
    Chandley P; Subba P; Rohatgi S
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.